{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:45:52Z","timestamp":1788911152035,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["405661\/2018-5; 308429\/2018-4"],"award-info":[{"award-number":["405661\/2018-5; 308429\/2018-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s10067-020-05519-0","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T22:03:01Z","timestamp":1606168981000},"page":"1881-1887","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis\u2014time to reconsider treatment guidelines? A case series and review of literature"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4370-3294","authenticated-orcid":false,"given":"Francisco Airton Castro","family":"Rocha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2411-6708","authenticated-orcid":false,"given":"Ana Carolina Matias Dinelly","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6887-8659","authenticated-orcid":false,"given":"Jailson Rodrigues","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2130-1246","authenticated-orcid":false,"given":"Atul","family":"Deodhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"issue":"9","key":"5519_CR1","doi-asserted-by":"publisher","first-page":"e106408","DOI":"10.1371\/journal.pone.0106408","volume":"9","author":"N Graudal","year":"2014","unstructured":"Graudal N, Hubeck-Graudal T, Tarp S, Christensen R, J\u00fcrgens G (2014) Effect of combination therapy on joint destruction in rheumatoid arthritis: a network meta-analysis of randomized controlled trials. PLoS One 9(9):e106408. https:\/\/doi.org\/10.1371\/journal.pone.0106408eCollection 2014","journal-title":"PLoS One"},{"issue":"4","key":"5519_CR2","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/acr.23875","volume":"72","author":"S Singh","year":"2020","unstructured":"Singh S, Fumery M, Singh AG, Singh N, Prokop LJ, Dulai PS, Sandborn WJ, Curtis JR (2020) Comparative risk of cardiovascular events with biologic and synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis. Arthritis Care Res 72(4):561\u2013576. https:\/\/doi.org\/10.1002\/acr.23875","journal-title":"Arthritis Care Res"},{"issue":"1","key":"5519_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/annrheumdis-2017-211544","volume":"77","author":"C Molnar","year":"2018","unstructured":"Molnar C, Scherer A, Baraliakos X, de Hooge M, Micheroli R, Exer P, Kissling RO, Tamborrini G, Wildi LM, Nissen MJ, Zufferey P, Bernhard J, Weber U, Landew\u00e9 RBM, van der Heijde D, Ciurea A (2018) Rheumatologists of the Swiss Clinical Quality Management Program. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis 77(1):63\u201369. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211544","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"5519_CR4","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1002\/art.38070","volume":"65","author":"N Haroon","year":"2013","unstructured":"Haroon N, Inman R, Learch TJ, Weisman MH, Lee M, Rahbar MH, Ward MM, Reveille JD, Gensler LS (2013) The impact of tumor necrosis factor \u03b1 inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum 65(10):2645\u20132654. https:\/\/doi.org\/10.1002\/art.38070","journal-title":"Arthritis Rheum"},{"issue":"7","key":"5519_CR5","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/acr.23097","volume":"69","author":"F Maas","year":"2017","unstructured":"Maas F, Arends S, Brouwer E, Essers I, van der Veer E, Efde M, van Ooijen PMA, Wolf R, Veeger NJGM, Bootsma H, Wink FR, Spoorenberg A (2017) Reduction in spinal radiographic progression in ankylosing spondylitis patients receiving prolonged treatment with tumor necrosis factor inhibitors. Arthritis Care Res 69(7):1011\u20131019. https:\/\/doi.org\/10.1002\/acr.23097","journal-title":"Arthritis Care Res"},{"issue":"4","key":"5519_CR6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/acr.21878","volume":"65","author":"S Bethi","year":"2013","unstructured":"Bethi S, Dasgupta A, Weisman MH, Learch TJ, Gensler LS, Davis JC Jr, Reveille JD, Ward MM (2013) Functional limitations due to axial and peripheral joint impairments in patients with ankylosing spondylitis: are focused measures more informative? Arthritis Care Res 65(4):607\u2013614. https:\/\/doi.org\/10.1002\/acr.21878","journal-title":"Arthritis Care Res"},{"issue":"20","key":"5519_CR7","doi-asserted-by":"publisher","first-page":"30480","DOI":"10.1016\/j.arth.2020.04.092","volume":"S0883\u20135403","author":"K Boontanapibul","year":"2020","unstructured":"Boontanapibul K, Steere JT, Amanatullah DF, Huddleston JI 3rd, Maloney WJ, Goodman SB (2020) Diagnosis of osteonecrosis of the femoral head: too little, too late, and independent of etiology. J Arthroplast S0883\u20135403(20):30480. https:\/\/doi.org\/10.1016\/j.arth.2020.04.092","journal-title":"J Arthroplast"},{"issue":"3","key":"5519_CR8","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/rheumatology\/key128","volume":"58","author":"D van der Heijde","year":"2019","unstructured":"van der Heijde D, Braun J, Deodhar A, Baraliakos X, Landew\u00e9 R, Richards HB, Porter B, Readie A (2019) Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis. Rheumatology (Oxford) 58(3):388\u2013400. https:\/\/doi.org\/10.1093\/rheumatology\/key128","journal-title":"Rheumatology (Oxford)"},{"key":"5519_CR9","doi-asserted-by":"publisher","first-page":"1759720X2090604","DOI":"10.1177\/1759720X20906040","volume":"12","author":"X Baraliakos","year":"2020","unstructured":"Baraliakos X, Gensler LS, D\u2019Angelo S, Iannone F, Favalli EG, de Peyrecave N, Auteri SE, Caporali R (2020) Biologic therapy and spinal radiographic progression in patients with axial spondyloarthritis: a structured literature review. Ther Adv Musculoskelet Dis 12:1759720X20906040. https:\/\/doi.org\/10.1177\/1759720X20906040","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"2","key":"5519_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/acr.21821","volume":"65","author":"MM Ward","year":"2013","unstructured":"Ward MM, Learch TJ, Gensler LS, Davis JC Jr, Reveille JD, Weisman MH (2013) Regional radiographic damage and functional limitations in patients with ankylosing spondylitis: differences in early and late disease. Arthritis Care Res 65(2):257\u2013265. https:\/\/doi.org\/10.1002\/acr.21821","journal-title":"Arthritis Care Res"},{"issue":"11","key":"5519_CR11","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1726-4901(09)70432-0","volume":"72","author":"Y-C Lin","year":"2009","unstructured":"Lin Y-C, Liang T-H, Chen W-S, Lin H-Y (2009) Differences between juvenile-onset ankylosing spondylitis and adult-onset ankylosing spondylitis. J Chin Med Assoc 72(11):573\u2013580. https:\/\/doi.org\/10.1016\/S1726-4901(09)70432-0","journal-title":"J Chin Med Assoc"},{"issue":"10","key":"5519_CR12","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/art.41042","volume":"71","author":"MM Ward","year":"2019","unstructured":"Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, Haroon N, Borenstein D, Wang R, Biehl A, Fang MA, Louie G, Majithia V, Ng B, Bigham R, Pianin M, Shah AA, Sullivan N, Turgunbaev M, Oristaglio J, Turner A, Maksymowych WP, Caplan L (2019) 2019 update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network Recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheum 71(10):1599\u20131613. https:\/\/doi.org\/10.1002\/art.41042","journal-title":"Arthritis Rheum"},{"issue":"3","key":"5519_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.22088\/cjim.9.3.303","volume":"9","author":"K Maatallah","year":"2018","unstructured":"Maatallah K, Mahmoud I, Belghali S, Ben Abdelghani K, Saidane O, Bouajina E, Laatar A, Tekaya R, Abdelmoula L (2018) Reparative radiological changes of hip joint after TNF inhibitors in ankylosing spondylitis. Caspian J Intern Med 9(3):303\u2013305. https:\/\/doi.org\/10.22088\/cjim.9.3.303","journal-title":"Caspian J Intern Med"},{"issue":"8","key":"5519_CR14","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s10067-013-2263-x","volume":"32","author":"M Konsta","year":"2013","unstructured":"Konsta M, Sfikakis PP, Bournia VK, Karras D, Iliopoulos A (2013) Absence of radiographic progression of hip arthritis during infliximab treatment for ankylosing spondylitis. Clin Rheumatol 32(8):1229\u20131232. https:\/\/doi.org\/10.1007\/s10067-013-2263-x","journal-title":"Clin Rheumatol"},{"issue":"2","key":"5519_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5371\/hp.2013.25.2.135","volume":"25","author":"Y-C Kim","year":"2013","unstructured":"Kim Y-C, Moon SW (2013) Etanercept treatment in ankylosing spondylitis hip lesions. Hip Pelvis 25(2):135\u2013140. https:\/\/doi.org\/10.5371\/hp.2013.25.2.135","journal-title":"Hip Pelvis"},{"issue":"6","key":"5519_CR16","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s00296-011-1844-8","volume":"32","author":"F Lian","year":"2012","unstructured":"Lian F, Yang X, Liang L, Xu H, Zhan Z, Qiu Q, Ye Y (2012) Treatment efficacy of etanercept and MTX combination therapy for ankylosing spondylitis hip joint lesion in Chinese population. Rheumatol Int 32(6):1663\u20131667. https:\/\/doi.org\/10.1007\/s00296-011-1844-8","journal-title":"Rheumatol Int"},{"key":"5519_CR17","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0140-6736(04)15640-7","volume":"363","author":"L Klareskog","year":"2004","unstructured":"Klareskog L, van der Heijde D, de Jager JP et al (2004) Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 363:675\u2013681","journal-title":"Lancet"},{"key":"5519_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/art.21519","volume":"54","author":"FC Breedveld","year":"2006","unstructured":"Breedveld FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, van Vollenhoven R, Sharp J, Perez JL, Spencer-Green GT (2006) The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 54:26\u201337","journal-title":"Arthritis Rheum"},{"key":"5519_CR19","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/art.20982","volume":"52","author":"JS Smolen","year":"2005","unstructured":"Smolen JS, Han C, Bala M, Maini RN, Kalden JR, van der Heijde D, Breedveld FC, Furst DE, Lipsky PE, ATTRACT Study Group (2005) Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. Arthritis Rheum 52:1020\u20131030","journal-title":"Arthritis Rheum"},{"issue":"4","key":"5519_CR20","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10067-011-1700-y","volume":"30","author":"S Momohara","year":"2011","unstructured":"Momohara S, Tanaka E, Iwamoto T, Ikari K, Yamanaka H (2011) Reparative radiological changes of a large joint after adalimumab for rheumatoid arthritis. Clin Rheumatol 30(4):591\u2013592. https:\/\/doi.org\/10.1007\/s10067-011-1700-y","journal-title":"Clin Rheumatol"},{"issue":"6","key":"5519_CR21","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","volume":"76","author":"JS Smolen","year":"2017","unstructured":"Smolen JS, Landewe R, Bijlsma J et al (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76(6):960\u2013977. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210715","journal-title":"Ann Rheum Dis"},{"key":"5519_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/acr.22783","volume":"68","author":"JA Singh","year":"2016","unstructured":"Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC, Vaysbrot E, McNaughton C, Osani M, Shmerling RH, Curtis JR, Furst DE, Parks D, Kavanaugh A, O'Dell J, King C, Leong A, Matteson EL, Schousboe JT, Drevlow B, Ginsberg S, Grober J, St Clair EW, Tindall E, Miller AS, McAlindon T, American College of Rheumatology (2016) 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Care Res 68:1\u201325","journal-title":"Arthritis Care Res"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05519-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05519-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05519-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T01:32:34Z","timestamp":1620351154000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05519-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["5519"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05519-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,23]]},"assertion":[{"value":"13 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"FACR: Consulting, Advisory Boards: Ach\u00e9, Abbott, BMS, Grunenthal, Janssen, Novartis, Pfizer, ZodiacACMDP and JRL: NoneAD: Consulting, Advisory Boards: AbbVie, Amgen, Boehringer Ingelheim, Celgene, Eli Lilly, Galapagos, Glaxo Smith & Kline, Janssen, Novartis, Pfizer, UCBResearch Grants: AbbVie, Eli Lilly, Glaxo Smith & Kline, Novartis, Pfizer, UCB","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}